Opened - 31st Dec 2021Closed - 5th Jan 2022Listed - 13th Jan 2022
Should I apply for Fabino Life Sciences SME IPO?
A total of 1 recommendations were tracked for Fabino Life Sciences SME IPO. Out of 1 , 0 financial institutes/analysts have given rating for Subscribe, 0 for May Apply (50-50), 1 for Avoid and 0 hasn't given any rating. In terms of percentage 0% institutes has rated Fabino Life Sciences SME IPO for subscribe.
₹36.00 per share
Issue Price
IPO Recommendations (0 Reviews)
Review By
Apply
May Apply
Neutral
Avoid
Not Rated
Count
0
0
0
0
0
%
0
0
0
0
0
Last Updated on 13-May-2026 10:31:36
₹0
Live GMP
6.93x
Subscription
₹3.24 Cr
Total Issue Size
-
Est. Listing
Fabino Life Sciences SME IPO Recommendations. Total:1, Subscribe:0, Avoid:1
